Arena Pharmaceuticals Announces First Quarter 2009 Financi...(net loss per share allocable to com...)

Date:5/11/2009

net loss per share allocable to common stockholders, basic and diluted 74,189 73,605 Arena Pharmaceuticals, Inc. Condensed Consolidated Balance Sheet Data (In thousands) March 31, December 31, 2009 2008 (unaudited) (Note) Assets Cash, cash equivalents and short-term investments $70,257 $110,129 Accounts receivable 1,795 1,823 Other current assets 3,898 5,031 Land, property and equipment, net 99,028 102,740 Acquired technology and other non-current assets 20,533 21,608 Total assets $195,511 $241,331 Liabilities and Stockholders' Equity Accounts payable, accrued liabilities and warrant liability $39,315 $46,789 Total deferred revenues 4,049 4,049 Total lease financing obligations and other long-term liabilities 87,155 72,861 Total stockholders' equity 64,992 117,632 Total liabilities and stockholders' equity $195,511 $241,331

Note: The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of that date.

'/>"/>

SOURCE Arena Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
2. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
3. Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
6. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
7. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
10. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
11. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference